Glycemic Stability Through Islet‐After‐Kidney Transplantation Using an Alemtuzumab‐Based Induction Regimen and Long‐Term Triple‐Maintenance Immunosuppression-Reference-Cited by-同舟云学术

Glycemic Stability Through Islet‐After‐Kidney Transplantation Using an Alemtuzumab‐Based Induction Regimen and Long‐Term Triple‐Maintenance Immunosuppression

Published:2015-08-19 Issue:1 Volume:16 Page:246-253
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Nijhoff M. F.¹²,Engelse M. A.²,Dubbeld J.³,Braat A. E.³,Ringers J.³,Roelen D. L.⁴,Erkel A. R.⁵,Spijker H. S.²,Bouwsma H.²,Boog P. J. M.²,Fijter J. W.²,Rabelink T. J.²,Koning E. J. P.¹²

Affiliation:

1. Department of Medicine, Division of Endocrinology and MetabolismLeiden University Medical CentreLeidenthe Netherlands

2. Division of Nephrology and TransplantationLeiden University Medical CentreLeidenthe Netherlands

3. Departments of SurgeryLeiden University Medical CentreLeidenthe Netherlands

4. ImmunohematologyLeiden University Medical CentreLeidenthe Netherlands

5. RadiologyLeiden University Medical CentreLeidenthe Netherlands

Funder

Diabetes Fonds

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy